Immunotherapy after bladder cancer surgery may reduce recurrence, study shows
New research from Memorial Sloan Kettering Cancer Center (MSK) medical oncologist Dean Bajorin, MD, and colleagues found that patients who received nivolumab (Opdivo) after bladder cancer surgery reduced their overall risk ...
Jun 4, 2021
0
12